why choose us

Course: PARP-Inhibitor Combination Treatments: Biomarker Testing, Safety, and Efficacy in a Rapidly Changing Metastatic Prostate Cancer (mPC) Landscape

CME Credits: 2.25

Released: 2026-08-07


View Full Course